Pharmacy benefits managers, or PBMs, are meant to act as a middleman between drug manufacturers and insurance companies to lower drug prices. But some lawmakers have questioned if that’s really the case. The Senate approved a bill some lawmakers are calling the most aggressive PBM legislation they have seen.

Generic drugs gave Americans access to effective, cheap prescription medications. It’s saved them trillions of dollars over the past few decades. But there are signs this vital industry may be in deep trouble.

The Federal Trade Commission says drug makers are gaming the system in order to keep drug prices high by filing what it describes as "junk patents".

The Jane Pauley Community Health Center held a ribbon cutting Wednesday on the east side of Indianapolis for a new pharmacy that aims to lower the price of prescription drugs.

For the first time in its 58-year history, Medicare, the public health insurance program for seniors, will have the power to ask for price cuts from drugmakers thanks to the Inflation Reduction Act passed last year.

Congress is debating a Democratic proposal, H.R.3, that would allow the federal government to negotiate prescription drug prices in an effort to lower costs.

The new price -- starting Jan. 1 -- will be about $80 per vial and comparable to how much a vial of Lilly's brand name Humalog insulin cost in 2008.

After a report criticized Eli Lilly and Co. for not doing enough to make affordable insulin available, the company launched a campaign Thursday to raise awareness of their discount options.

Indiana lawmakers heard from drug makers, consumers, doctors and industry experts about some of the driving factors of drug pricing.

The group delivered a call for Young to sign on as a co-sponsor of the Prescription Drug Pricing Reduction Act moving through Congress.